Is phenoxybenzamine a non-competitive antagonist? Exploring its mechanism of action
•
2 min read
According to reputable sources like the National Cancer Institute, phenoxybenzamine is an alpha-adrenergic antagonist with antihypertensive properties, and a key aspect of its pharmacology is its action as a non-competitive, irreversible blocker. Understanding this unique mechanism of action is vital for appreciating its clinical application, particularly in the management of catecholamine-secreting tumors like pheochromocytoma.
